Effect of salvia officinalis in treatment of psoriasis

Comparison of the complications and efficacy of topical clobetasol ointment with salvia officinalis ointment in the treatment of plaque psoriasis patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210202050214N1

Enrollment

Registered

2021-02-07

Start date

2021-04-21

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plaque psoriasis. Psoriasis

Interventions

Intervention group: In this group every patient receives salvia officinalis ointment 3 times a day for a maximum 2 months , in average 300 miligrams salvia officinalis ointment %3 which contains glyce

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Plaque psoriasis patients Ability to follow up patients Not use other treatments

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Measuring patch scale size. Timepoint: Measuring patch scales every two weeks for a maximum two months. Method of measurement: Ruler.	—

Secondary

Measure	Time frame
Measuring erythema eara size. Timepoint: Every two weeks until for a maximum two months. Method of measurement: Ruler.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirhossein Mosalman haghighi

Bandare-abbas University of Medical Sciences

amrhosnmosalman@gmail.com+98 76 3334 6994

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026